DR. HEXEBERGS KLINIKK AS

Dr. Hexeberg | MATVAREINTOLERANSER OG MAGE-/TARMSYKDOMMER

Dr. Hexeberg, Klinikken baserer seg på å bruke mat som medisin med fokus på et individuelt tilpasset kosthold. Erfaringene vi har gjort i årene siden 2010 har gjort at vi har fått erfaring fra et større spekter av diagnoser / problemstillinger og en større forståelse for et individuelt tilpasset kosthold. Vi anbefaler også tilskudd av vitaminer og mineraler og eventuelt medikamenter når vi synes dette er nødvendig. MATVAREINTOLERANSER OG MAGE-/TARMSYKDOMMER behandles ofte med råd fra oss.

Keywords

general practicesmunicipal doctorsmunicipal emergency room

Organization

CEO: EH
Erik Hexeberg1957
Chairman of the board: EH
Erik Hexeberg1957
Years since formation: 15 years; since Nov 16, 2010
Type: Limited company
VAT registered: No
Number of employees: 0

Ownership

Number of shares and share classes: 100; 1 share class
Total number of shareholders: 1; company
Belongs to group of

Financials

Total operating income 2024: 7,207,730; NOK
Annual total result 2024: -120,892; NOK
Total equity 2024: 350,158; NOK

Last update: May 17, 2025

Management

Management / administration

Name	Role	Shares
EH Erik Hexeberg 1957	Managing Director/CEO	50 % indirectly

Board

Name	Role	Shares
EH Erik Hexeberg 1957	Chairman	50 % indirectly
SH Sofie Hexeberg 1960	Alternate Member	50 % indirectly

Others

Name	Role	Shares
K KNUDSEN REVISJONSBYRÅ AS	Auditor	-
E ECIT RÅD & REGNSKAP AS	Accountant	-

Top 10 individual shareholders

Name	Role	Shares
EH Erik Hexeberg 1957	Managing Director/CEO, Chairman	50 % indirectly
SH Sofie Hexeberg 1960	Alternate Member	50 % indirectly

Last update: Apr 13, 2023

Ownership

Company shareholders

Name	Share class	Total number of shares	Share
P POLYBOS AS	Ordinary shares	100	100 %

Shares owned by the DR. HEXEBERGS KLINIKK AS

Name	Share class	Total number of shares	Share
T TØNSBERG MEDISINSKE SENTER AS	Ordinary shares	5,371	4.55 %

Last update: Jun 2, 2025

Group structure

POLYBOS AS
Total operating income 2024: NOK 2,778,762
Operating profit 2024: NOK 343,599
Employees: 0

Financials

in NOK

Summary

Year	2024	2023	2022	2021
Total operating income	7,207,730	5,381,691	3,313,050	2,946,219
Annual Total Result	-120,892	439,974	456,429	-67,123
Total assets	1,472,681	798,127	488,391	242,473
Total liabilities	1,122,523	461,387	591,625	802,135
Total equity	350,158	336,740	-103,234	-559,662

P&L

Year	2024	2023	2022	2021
Total operating income	7,207,730	5,381,691	3,313,050	2,946,219
Total operating costs	7,329,258	4,817,283	2,751,572	3,012,678
Operating result	-121,528	564,408	561,478	-66,459
Financial income/costs	636	-975	-3,233	-664
Profit before tax	-120,892	563,433	558,246	-67,123
Total tax & extraordinary income/cost	0	123,459	101,817	0
Annual Total Result	-120,892	439,974	456,429	-67,123

Balance overview

Year	2024	2023	2022	2021
Total fixed assets	229,694	236,324	6,000	6,000
Total current assets	1,242,988	561,803	482,391	236,473
Total assets	1,472,681	798,127	488,391	242,473
Short term debt	1,022,523	361,387	491,625	702,135
Long term debt	100,000	100,000	100,000	100,000
Total liabilities	1,122,523	461,387	591,625	802,135
Contributed capital	234,310	100,000	100,000	100,000
Retained earnings	115,848	236,740	-203,234	-659,662
Total equity	350,158	336,740	-103,234	-559,662
Total equity and liabilities	1,472,681	798,127	488,391	242,473

DR. HEXEBERGS KLINIKK AS996 145 506